USA - engelsk - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride 10 mg in 1 ml - lidocaine hcl injections are indicated for production of local anesthesia by infiltration techniques such as percutaneous injection and by peripheral nerve block techniques such as brachial plexus and intercostal, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 426.4 mg (equivalent: lidocaine hydrochloride, qty 400 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.32 mg (equivalent: lidocaine hydrochloride, qty 20 mg) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 42.64 mg (equivalent: lidocaine hydrochloride, qty 40 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 53.3 mg (equivalent: lidocaine hydrochloride, qty 50 mg) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 213.2 mg (equivalent: lidocaine hydrochloride, qty 200 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 106.6 mg (equivalent: lidocaine hydrochloride, qty 100 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride - lidocaine noridem solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia, peripheral nerve block, epidural block, subarachnoid block.

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

laboratoire renaudin - chlorhydrate de lidocaïne anhydre 20 mg sous forme de : lidocaïne (chlorhydrate de) monohydraté - solution - 20 mg - pour 1 ml > chlorhydrate de lidocaïne anhydre 20 mg sous forme de : lidocaïne (chlorhydrate de monohydraté - antiarythmiques - classe pharmacothérapeutique : antiarythmique (classe ib) - code atc : système cardiovasculaire (c01bb01)lidocaine chlorhydrate renaudin 20 mg/ml, solution pour injection/perfusion contient la substance active chlorhydrate de lidocaïne monohydraté.la lidocaïne est un médicament antiarythmique appartenant au groupe des stabilisants membranaires (classe ib). la lidocaïne empêche essentiellement que le sodium, nécessaire à la contraction des cellules musculaires, puisse pénétrer dans les cellules musculaires cardiaques immédiatement après une contraction du cœur. il pourra pénétrer dans les cellules du muscle cardiaque un peu plus tard ce qui va retarder la contraction du cœur suivante. en conséquence, le cœur commence à battre plus lentement.ce médicament est administré pour prévenir ou traiter une augmentation anormale du rythme cardiaque (appelée arythmie ventriculaire), lorsque celle-ci peut être mortelle.

USA - engelsk - NLM (National Library of Medicine)

baxter healthcare corporation - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride 4 mg in 1 ml - lidocaine hydrochloride administered intravenously is specifically indicated in the acute management of (1) ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery and (2) life-threatening arrhythmias which are ventricular in origin, such as occur during acute myocardial infarction. hypersensitivity reactions, including anaphylactic reactions, have been reported with lidocaine. lidocaine hydrochloride is contraindicated in patients with a history of hypersensitivity to local anesthetics of the amide type. lidocaine is contraindicated in patients with stokes-adams syndrome, wolff-parkinson-white syndrome, or with severe degrees of sinoatrial, atrioventricular, or intraventricular block.

USA - engelsk - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hcl injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.  lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.